Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer

Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer

Abstract Background Adjuvant endocrine therapy undoubtedly prolongs the time to recurrence for patients with hormone-positive early breast cancer. Extended endocrine therapy to 10 years or longer has been expected to bring a greater clinical advantage. However, the related research conclusions are c...

Full description

Bibliographic Details
Main Authors: Li Li, Bingmei Chang, Xiaoyue Jiang, Xueke Fan, Yingrui Li, Teng Li, Shanshan Wu, Jun Zhang, Seyed Kariminia, Qin Li
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
Breast cancer
Extended endocrine treatment
Tamoxifen
Aromatase inhibitor
Disease-free survival
Online Access:http://link.springer.com/article/10.1186/s12885-018-4878-4

Internet

http://link.springer.com/article/10.1186/s12885-018-4878-4

Similar Items